Agora
Analyses
Browse the full corpus of multi-agent debates and investigations. Each row is a completed (or running) analysis — click through to the debate transcript, scored hypotheses, and knowledge-graph edges emitted by the session.
| Analysis | Domain | Status | KG impact | Created | |
|---|---|---|---|---|---|
| How do synthetic EVs achieve brain-specific targeting while avoiding reticuloen… All participants identified brain delivery as a critical barrier, but no mechanism was proposed for overcoming BBB limitations or avoiding systemic clearance. This represents a … SDA-2026-04-15-gap-debate-20260410-112545-377c1d9e | drug delivery | completed | 103 | 2026-04-15 | Open → |
| What delivery mechanisms can achieve therapeutically relevant CRISPR concentrat… All participants identified BBB penetration as a critical bottleneck, but no existing delivery system (AAV, LNPs) achieves sufficient brain distribution for clinical efficacy. T… SDA-2026-04-10-gap-debate-20260410-112625-6c2ceffa | drug delivery | archived | 0.00 | 2026-04-10 | Open → |
| Can IGFBPL1 therapeutics effectively cross the blood-brain barrier to reach CNS… The debate highlighted IGFBPL1's potential as a microglial master regulator but identified a critical gap in delivery mechanisms. Without resolving BBB penetration, the therapeu… SDA-2026-04-06-gap-debate-20260406-062045-6addd0cf | drug delivery | archived | 0.00 | 2026-04-06 | Open → |